St. Luke's University Health Network, Bethlehem, PA   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bethlehem PA United States (1872)

Organization Overview

First Clinical Trial
2013
NCT02233400
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

St Luke's Health University Network | St. Luke's University Health Network | St Luke's University Hospital and Health Network | St. Luke's University Hospital and Health Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 3)

Osteoarthritis, Knee (Phase 4)

Pain, Postoperative (Phase 4)

Skin Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 9